The company's lead product is the Coag-Sense PT/INR Monitoring System, which incorporates a novel direct micromechanical clot-detection technology.

The company's lead product is the Coag-Sense ® PT/INR Monitoring System, which incorporates a novel direct micromechanical clot-detection technology.

Bio-AMD, Inc. and Bio-AMD Holdings Ltd., our majority owned medical devices subsidiary here provides an update on its PT/INR COAG project and on other matters around its business.

PT-INR testing dominates the coagulation testing market mostly due to the prevalence of Warfarin as the most common anti-coagulation therapy prescribed by doctors.

The analyzer conducts rapid, reliable Prothrombin time testing (PT/INR); this gives the doctor an idea if the warfarin is working effectively with a properly prolonged coagulation cascade and clot ...